FDA to meet in December to review Pfizer Covid-19 vaccine

Pfizer is seeking emergency use of its Covid-19 vaccine in the US Picture: AP/Bebeto Matthews, File

US regulators will meet on December 10 to discuss whether to authorise the Covid-19 vaccine developed by Pfizer and German partner BioNTech for emergency use, the US Food and Drug Administration has said.

The move could deliver a limited amount of first shots of the vaccine as early as next month and eventually an end to the pandemic – but not after a long, hard winter.